Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · IEX Real-Time Price · USD
4.590
-0.040 (-0.86%)
Jul 22, 2024, 11:43 AM EDT - Market open
Achieve Life Sciences Employees
Achieve Life Sciences had 22 employees as of December 31, 2023. The number of employees increased by 2 or 10.00% compared to the previous year.
Employees
22
Change (1Y)
2
Growth (1Y)
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,241,682
Market Cap
158.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Rani Therapeutics Holdings | 140 |
| OptiNose | 132 |
| TriSalus Life Sciences | 112 |
| Vaxart | 109 |
| Compugen | 68 |
| Assertio Holdings | 53 |
| INmune Bio | 17 |
| FibroBiologics | 10 |
ACHV News
- 13 days ago - Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine - GlobeNewsWire
- 3 months ago - Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 - GlobeNewsWire
- 4 months ago - Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission - GlobeNewsWire